News
Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?
Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease, bolstering physicians’ excitement about an already-exploding class of new medicines.
“Imagine a future where we’re treating obesity and, in effect, treating these other obesity-related diseases” like hypertension, high cholesterol and type 2 diabetes, Dr. Ania Jastreboff, director of the Yale Obesity Research Center, who helped conduct the trial, said at a briefing Friday. “Treating obesity clearly improves health outcomes.”
Source: CNN Health